Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Collaborative Medicinal Development LLC wins AU$1 million grant award from FightMND
2019-04-18 01:11
China SXT Pharmaceuticals, Inc. Announces Pricing of a $15 Million PIPE Financing
2019-04-17 21:01
GC Pharma Marks 'World Hemophilia Day'
2019-04-16 10:57
Tessa Therapeutics Announces Collaboration with Merck Investigating the Combination of KEYTRUDA® (pembrolizumab) and Virus-Specific T Cell Therapy Targeting Human Papillomavirus in Cervical Cancer
2019-04-16 07:15
Shanghai Pharma Unveils Stock Incentive Plans to Accelerate Global Ambition
2019-04-15 20:00
CStone received IND approval in China for avapritinib Phase I/II bridging registrational study in patients with advanced gastrointestinal stromal tumors
2019-04-15 14:32
World First Development of an Arsenic-Peptide to Target Cancer
2019-04-12 14:00
Mallinckrodt's INOmax™ (Nitric Oxide) Gas, for Inhalation, Approved in Australia for Pulmonary Hypertension in Adults in Conjunction with Cardiovascular Surgery
2019-04-11 05:00
Dr Gillies O'Bryan-Tear Joins Clarity Pharmaceuticals' Board
2019-04-10 09:30
Antengene Corporation Announces Establishment of U.S. Subsidiary and Collaboration with the Baruch S. Blumberg Institute
2019-04-08 20:00
CStone Pharmaceuticals presented poster of pre-clinical result for CS1003 at AACR
2019-04-04 23:44
China SXT Pharmaceuticals, Inc. Receives National High-tech Enterprise Qualification
2019-04-02 18:30
Foresee Pharmaceuticals Announces Submission of NDA for FDA Approval of LMIS 50 mg
2019-03-30 04:06
Luye Pharma's Rykindo® Expected to Be the First Chinese Innovative Drug to Receive U.S. FDA Approval
2019-03-29 11:48
Transcenta Holding Announces Licensing Agreement with Lilly
2019-03-29 08:30
China SXT Pharmaceuticals, Inc. Announces Financial Results for the Six Months Ended September 30, 2018
2019-03-28 18:30
WuXi STA's New Drug Product Manufacturing Facility Passes First European MPA GMP Inspection
2019-03-27 14:00
GCAM Adds New Plasma Collection Center
2019-03-26 12:05
Dr Thomas Ramdahl Joins Clarity Pharmaceuticals' Board
2019-03-26 08:30
CStone appoints three distinguished oncology leaders Drs. Paul A. Bunn, Jr., Elizabeth M. Jaffee and Richard S. Finn to its Scientific Advisory Board
2019-03-25 15:14
1
124
125
126
127
128
158